Skip to content

controlled group:sorafenib

2 trials

Sponsors

Department of integrative oncology, Changhai Hospital, Changhai Hospital of Traditional Chinese Medicine, Second Military Medical University

Conditions

Hepatocellular carcinomahepetocelluler carcinoma

Related Papers